Tag: OTCQX:CRTPF

March 26, 2020

Cardiol Therapeutics CEO David Elsley: Shoppers Supply Agreement a Significant Milestone

Cardiol Therapeutics CEO David Elsley joined the Investing News Network to discuss the company’s recent supply agreement.
July 25, 2019

Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), focused on producing pharmaceutical CBD products and developing innovative therapies for...
June 10, 2019

Cardiol Therapeutics to Webcast Annual General Meeting on June 12

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical...
June 3, 2019

Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical cannabidiol (CBD)...